NLS Pharmaceutics AG Statistics
Total Valuation
NLSP has a market cap or net worth of $8.82 million. The enterprise value is $7.15 million.
Important Dates
The next estimated earnings date is Monday, July 7, 2025, after market close.
| Earnings Date | Jul 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NLSP has 3.16 million shares outstanding. The number of shares has increased by 61.70% in one year.
| Current Share Class | 3.16M |
| Shares Outstanding | 3.16M |
| Shares Change (YoY) | +61.70% |
| Shares Change (QoQ) | +94.34% |
| Owned by Insiders (%) | 20.38% |
| Owned by Institutions (%) | 11.44% |
| Float | 1.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.27 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.69
| Current Ratio | 2.69 |
| Quick Ratio | 2.56 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.24 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -111.41% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -258.56% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$579,570 |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.80% in the last 52 weeks. The beta is 0.04, so NLSP's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | -61.80% |
| 50-Day Moving Average | 1.94 |
| 200-Day Moving Average | 2.66 |
| Relative Strength Index (RSI) | 68.48 |
| Average Volume (20 Days) | 326,963 |
Short Selling Information
The latest short interest is 72,299, so 2.29% of the outstanding shares have been sold short.
| Short Interest | 72,299 |
| Short Previous Month | 157,054 |
| Short % of Shares Out | 2.29% |
| Short % of Float | 4.28% |
| Short Ratio (days to cover) | 0.15 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.64M |
| Pretax Income | -12.17M |
| Net Income | -4.06M |
| EBITDA | -3.63M |
| EBIT | -3.64M |
| Earnings Per Share (EPS) | -$2.63 |
Full Income StatementBalance Sheet
The company has $1.67 million in cash and n/a in debt, giving a net cash position of $1.67 million or $0.53 per share.
| Cash & Cash Equivalents | 1.67M |
| Total Debt | n/a |
| Net Cash | 1.67M |
| Net Cash Per Share | $0.53 |
| Equity (Book Value) | 1.41M |
| Book Value Per Share | -0.42 |
| Working Capital | 1.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$4.27 million and capital expenditures -$3,917, giving a free cash flow of -$4.27 million.
| Operating Cash Flow | -4.27M |
| Capital Expenditures | -3,917 |
| Free Cash Flow | -4.27M |
| FCF Per Share | -$1.35 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |